Literature DB >> 6465364

Response of functional hallucinations to carbamazepine.

A M Kraft, I N Hassenfeld, M Zarr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6465364     DOI： 10.1176/ajp.141.8.1018a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

Review 1.  The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Authors:  C Simhandl; K Meszaros
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

2.  Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction.

Authors:  Motahareh Zeinivand; Arezo Nahavandi; Mahdie Zare
Journal:  Inflammopharmacology       Date:  2019-11-30       Impact factor: 4.473

Review 3.  Carbamazepine for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John McGrath
Journal:  Cochrane Database Syst Rev       Date:  2014-05-02

4.  Functional hallucinations in schizophrenia responding to adjunctive sodium valproate.

Authors:  Ravi Philip Rajkumar
Journal:  Indian J Psychol Med       Date:  2012-01

5.  Electroconvulsive Therapy in Functional Hallucination: Scope and Challenges.

Authors:  Sulochana Joshi; Rabi Shakya
Journal:  Case Rep Psychiatry       Date:  2017-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.